TCR Sequencing to Identify Responders in Patients with Stage III NSCLC Treated with Atezoluzimab with Chemoradiation (AFT-16).
- Citation:
- J Thorac Oncol vol 16 (3_suppl) S645
- Meeting Instance:
- IASLC (WCLC) 2020
- Year:
- 2021
- Type:
- Abstract
- Sub type:
- Funding:
- AFT
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 4020
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Genentech
- Grants:
- Corr. Author:
- Authors:
- Woo Yul Byun Helen Ross David Kozono James Urbanic Ryan Robb Tiffany Talabere Filiz Oezkan Daniel Spakowicz David Carbone Terence M. Williams
- Networks:
- CA043, CA249, IL043, LAPS-MA036, LAPS-OH007
- Study
- AFT-16
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: